<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:01:24Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4925463" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4925463</identifier><datestamp>2016-07-13</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neuromuscul Disord</journal-id>
      <journal-id journal-id-type="iso-abbrev">Neuromuscul. Disord</journal-id>
      <journal-title-group>
        <journal-title>Neuromuscular Disorders</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0960-8966</issn>
      <issn pub-type="epub">1873-2364</issn>
      <publisher>
        <publisher-name>Pergamon Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4925463</article-id>
      <article-id pub-id-type="pmcid">PMC4925463</article-id>
      <article-id pub-id-type="pmc-uid">4925463</article-id>
      <article-id pub-id-type="pmid">27212206</article-id>
      <article-id pub-id-type="publisher-id">S0960-8966(15)30072-9</article-id>
      <article-id pub-id-type="doi">10.1016/j.nmd.2016.05.003</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>TMEM5-</italic>associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Astrea</surname>
            <given-names>Guja</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pezzini</surname>
            <given-names>Ilaria</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Picillo</surname>
            <given-names>Ester</given-names>
          </name>
          <xref rid="af0015" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pasquariello</surname>
            <given-names>Rosa</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moro</surname>
            <given-names>Francesca</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ergoli</surname>
            <given-names>Manuela</given-names>
          </name>
          <xref rid="af0015" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Ambrosio</surname>
            <given-names>Paola</given-names>
          </name>
          <xref rid="af0015" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Amico</surname>
            <given-names>Adele</given-names>
          </name>
          <xref rid="af0020" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Politano</surname>
            <given-names>Luisa</given-names>
          </name>
          <xref rid="af0015" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santorelli</surname>
            <given-names>Filippo Maria</given-names>
          </name>
          <email>filippo3364@gmail.com</email>
          <xref rid="af0010" ref-type="aff">a</xref>
          <xref rid="co0010" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af0010"><label>a</label>IRCCS Stella Maris, Pisa, Italy</aff>
      <aff id="af0015"><label>b</label>Department of Experimental Medicine, Cardiomyology and Medical Genetics, Second University of Naples, Naples, Italy</aff>
      <aff id="af0020"><label>c</label>Unit for Neuromuscular and Neurodegenerative Disorders, IRCCS Bambino GesÃ¹ Children's Hospital, Rome, Italy</aff>
      <author-notes>
        <corresp id="co0010"><label>*</label>Corresponding author. Molecular Medicine, IRCCS Stella Maris, via dei Giacinti 2, 56128 Calambrone, Pisa, Italy. Tel.: + 39 050 886275; fax: +39 050 886247.Molecular MedicineIRCCS Stella Marisvia dei Giacinti 2, 56128 CalambronePisaItaly <email>filippo3364@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <volume>26</volume>
      <issue>7</issue>
      <fpage>459</fpage>
      <lpage>461</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2016 The Authors</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract abstract-type="author-highlights" id="ab0010">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0010">
              <label>â¢</label>
              <p>We studied a CMD patient with structural brain abnormalities.</p>
            </list-item>
            <list-item id="u0015">
              <label>â¢</label>
              <p>Next-generation sequencing identified a reported variant in <italic>TMEM5</italic>.</p>
            </list-item>
            <list-item id="u0020">
              <label>â¢</label>
              <p>We expanded the spectrum of <italic>TMEM5</italic>-associated disorders.</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <abstract id="ab0015">
        <p>The dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement. Recently, mutations in <italic>TMEM5</italic> have been described in severe dystroglycanopathies. We present the clinical, molecular and neuroimaging features of an Italian boy who had delayed developmental milestones with mild limb-girdle muscle involvement, bilateral frontotemporal polymicrogyria, moderate intellectual disability, and no cerebellar involvement. He also presented a cochlear dysplasia and harbored a reported mutation (p.A47Rfs*42) in <italic>TMEM5</italic>, detected using targeted next-generation sequencing. The relatively milder muscular phenotype and associated structural brain abnormalities distinguish this case from previously reported patients with severe dystroglycanopathies and expand the spectrum of <italic>TMEM5</italic>-associated disorders.</p>
      </abstract>
      <kwd-group id="kwd0010">
        <title>Keywords</title>
        <kwd>Congenital muscular dystrophy</kwd>
        <kwd>
          <italic>TMEM5</italic>
        </kwd>
        <kwd>Polymicrogyria</kwd>
        <kwd>Cochlear dysplasia</kwd>
        <kwd>Limb-girdle muscle weakness</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0010">
      <label>1</label>
      <title>Introduction</title>
      <p>The dystroglycanopathies are heterogeneous clinical conditions characterized by reduced glycosylation of alpha-dystroglycan (Î±-DG) in skeletal muscles <xref rid="bib0010" ref-type="bibr">[1]</xref>. Clinical presentations range from prenatal brain malformations to congenital muscular dystrophies (CMDs) with various combinations of ocular involvement and mental retardation, and late-onset limb-girdle muscular dystrophies (LGMDs) <xref rid="bib0010" ref-type="bibr">[1]</xref>. The list of disease-associated genes has grown rapidly with the advent of next-generation sequencing (NGS) technologies which can be combined with protein network analysis <xref rid="bib0015" ref-type="bibr">[2]</xref>, and this has significantly expanded the spectrum of clinical phenotypes <xref rid="bib0020" ref-type="bibr">[3]</xref>.</p>
      <p><italic>TMEM5</italic> encodes a transmembrane protein thought to be involved in the glycosylation of dystroglycan <xref rid="bib0015" ref-type="bibr">[2]</xref>. Mutations in <italic>TMEM5</italic> were initially described in three infants presenting congenital muscle hypotonia and severe brain malformations meeting the clinical diagnosis of WalkerâWarburg syndrome (WWS)/muscleâeyeâbrain disease (MEB) <xref rid="bib0015" ref-type="bibr">[2]</xref>, the most severe, rapidly lethal forms of CMD <xref rid="bib0010" ref-type="bibr">[1]</xref>. A study of an undiagnosed cohort of fetuses with cobblestone type II lissencephaly (cobblestone-LIS) <xref rid="bib0025" ref-type="bibr">[4]</xref>, a peculiar brain malformation with characteristic MRI abnormalities, revealed five additional mutations.</p>
      <p>We herein expand the phenotypic spectrum of disorders associated with mutations in <italic>TMEM5</italic>, describing a patient who presented repeatedly elevated CK levels and mild limb-girdle muscular involvement, and whose NGS-based molecular testing disclosed an already reported variant.</p>
    </sec>
    <sec id="s0015">
      <label>2</label>
      <title>Case report</title>
      <p>This 13-year-old boy was born to non-consanguineous healthy parents at 38 weeks of gestation. At birth he presented with a low birth weight (2600âg), normal head circumference (36âcm) and respiratory distress. His neurodevelopment was globally delayed as he had achieved the sitting position at the age of 8 months and walked unaided at 23 months. A firstEEG recording, ordered by the general pediatrician because of developmental delay at the age of 14 months, showed polymorphic slow waves but no seizures. At the age of 3 years, medical examinations prior to surgery for undescended testis revealed elevated serum creatine kinase (CK) levels (2054âU/L, normal &lt;190). Despite an improvement in his motor skills, due to speech and psychomotor therapy, the patient underwent a skeletal muscle biopsy at the age of 4 years because of persistently elevated CK levels (3227âU/L) and EMG features suggestive of a myopathy. Histochemistry showed a dystrophic pattern with abnormal variation in fiber size, necrosis and few scattered degenerative fibers, whereas immunofluorescent stains for dystrophin, merosin/laminin-a2 (300âkDa antibody) and sarcoglycans were normal (not shown). The glycosylated forms of Î±-DG were not analyzed because of lack of material.</p>
      <p>At the age of 5 years â when his weight was 24âkg (97Â° percentile), height 114âcm (85Â°), and head circumference 50âcm (50Â°) â a brain MRI showed bilateral frontotemporal polymicrogyria (<xref rid="f0010" ref-type="fig">Fig.Â 1AâC</xref>), abnormal signals in the frontoparietal white matter bilaterally, with a patchy, confluent appearance (<xref rid="f0010" ref-type="fig">Fig.Â 1DâF</xref>), a dysplastic cerebellar cortex, and small subcortical cerebellar cysts (<xref rid="f0010" ref-type="fig">Fig.Â 1G</xref>). Hypoplasia of the pons with a ventral cleft and a dilated and dysmorphic fourth ventricle (<xref rid="f0010" ref-type="fig">Fig.Â 1H</xref>), and also bilateral cochlear dysplasia (<xref rid="f0010" ref-type="fig">Fig.Â 1I</xref>), were also seen.</p>
      <p>The patient attended yearly neuromuscular follow-ups, and showed a stable clinical course. At the time of latest examination when he was age 13, his growth was normal but he revealed relatively mild symmetric proximal weakness: he was able to walk 10âm in 6âs, to run 10âm in 3.3âs, and to rise from the floor in 12âs. His forced vital capacity was 63% of normal values. Ocular and cardiac evaluations were normal and there were neither gait and trunk ataxia nor dysmetria and nystagmus. Neuropsychological assessment revealed a moderate mental delay with low verbal skills and slight deficits in attention, short term working memory, and problem solving. Consistently with the bilateral cochlear dysplasia observed on neuroimaging, brain auditory evoked potentials revealed mild hearing impairment, especially in the right ear.</p>
      <p>This case was included in a group of undiagnosed muscular dystrophy patients to be analyzed by Dystroplex, an extended NGS testing panel able to investigate, in a single tube, the coding regions of 93 genes linked to CMDs, LGMDs or related diseases (see supplementary <xref rid="s0025" ref-type="fn">Appendix</xref>). We detected the already described homozygous c.139delG:p.(A47Rfs*42) in <italic>TMEM5</italic>
<xref rid="bib0015" ref-type="bibr">[2]</xref>. The mutation was confirmed by Sanger sequencing and found to be heterozygous in the healthy parents. Two additional predicted deleterious variants [the heterozygous c.1654-6A&gt;G in <italic>POMT2,</italic> described in a child with LGMD and low Î±-DG <xref rid="bib0030" ref-type="bibr">[5]</xref>, and the novel c.1079A&gt;G: p.(Y360C) in <italic>DOLK</italic>] were also detected in the patient and his father.</p>
    </sec>
    <sec id="s0020">
      <label>3</label>
      <title>Discussion</title>
      <p>To date, 12 patients harboring mutations in <italic>TMEM5</italic> have been described. Two siblings carried the homozygous p.A47Rfs*42 mutation and had severe intellectual disability with autistic features, microcephaly, broad-based gait, 20-fold increased levels of serum CK, and a dystrophic pattern on muscle biopsy. In one case, neuroimaging revealed brainstem atrophy, dilated ventricles, widespread pachygyria and significant white matter changes <xref rid="bib0015" ref-type="bibr">[2]</xref>. A nonsense p.R340* was detected in the same study in an unrelated WWS newborn who had muscle hypotonia, right microphthalmia, bilateral opaque cornea, cranial ultrasound evidence of hydrocephalus, and occipital encephalocele, and died at the age of 22 months <xref rid="bib0015" ref-type="bibr">[2]</xref>. Lastly, nine fetuses in five families with cobblestone-LIS harbored different loss-of-function changes <xref rid="bib0025" ref-type="bibr">[4]</xref>.</p>
      <p>The present case report lies at the mildest end of the possible spectrum of <italic>TMEM5</italic>-associated disorders. Unlike previously reported cases carrying p.A47Rfs*42, our patient showed only mildly delayed achievement of motor milestones and neither signs of cerebellar involvement nor microcephaly; furthermore, he presented mild muscular weakness that involved the lower limb-girdle muscles but did not prevent him from running or using a bike, even though he tired quickly. The phenotype appeared severe on brain imaging, yet resulted in only moderate intellectual disability and the boy was able to attend school profitably without needing a support teacher. Our data offer a further example of the value of targeted NGS technologies in clinical settings. The striking differences with earlier <italic>TMEM</italic>5-related cases provide a further illustration of the fact that clinical presentation in the dystroglycanopathies cannot be explained solely by the specific gene mutation <xref rid="bib0035" ref-type="bibr">[6]</xref>. The question of whether other modifiers of the Î±-DG glycosylation pathway might have contributed to the milder course seen in our patient remains unanswered.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib0010">
        <label>1</label>
        <element-citation publication-type="journal" id="sr0010">
          <person-group person-group-type="author">
            <name>
              <surname>Muntoni</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Torelli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies</article-title>
          <source>Curr Opin Neurol</source>
          <volume>24</volume>
          <year>2011</year>
          <fpage>437</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="pmid">21825985</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0015">
        <label>2</label>
        <element-citation publication-type="journal" id="sr0015">
          <person-group person-group-type="author">
            <name>
              <surname>Jae</surname>
              <given-names>L.T.</given-names>
            </name>
            <name>
              <surname>Raaben</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Riemersma</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Deciphering the glycosylome of dystroglycanopathies using haploid screens for Lassa virus entry</article-title>
          <source>Science</source>
          <volume>340</volume>
          <year>2013</year>
          <fpage>479</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="pmid">23519211</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0020">
        <label>3</label>
        <element-citation publication-type="journal" id="sr0020">
          <person-group person-group-type="author">
            <name>
              <surname>Belaya</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>RodrÃ­guez Cruz</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W.W.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies</article-title>
          <source>Brain</source>
          <volume>138</volume>
          <year>2015</year>
          <fpage>2493</fpage>
          <lpage>2504</lpage>
          <pub-id pub-id-type="pmid">26133662</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0025">
        <label>4</label>
        <element-citation publication-type="journal" id="sr0025">
          <person-group person-group-type="author">
            <name>
              <surname>Vuillaumier-Barrot</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bouchet-Seraphin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chelbi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly</article-title>
          <source>Am J Hum Genet</source>
          <volume>91</volume>
          <year>2012</year>
          <fpage>1135</fpage>
          <lpage>1143</lpage>
          <pub-id pub-id-type="pmid">23217329</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0030">
        <label>5</label>
        <element-citation publication-type="journal" id="sr0030">
          <person-group person-group-type="author">
            <name>
              <surname>Godfrey</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mein</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan</article-title>
          <source>Brain</source>
          <volume>130</volume>
          <year>2007</year>
          <fpage>2725</fpage>
          <lpage>2735</lpage>
          <pub-id pub-id-type="pmid">17878207</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0035">
        <label>6</label>
        <element-citation publication-type="journal" id="sr0035">
          <person-group person-group-type="author">
            <name>
              <surname>Mercuri</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Muntoni</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>The ever-expanding spectrum of congenital muscular dystrophies</article-title>
          <source>Ann Neurol</source>
          <volume>72</volume>
          <year>2012</year>
          <fpage>9</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">22829265</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0030" sec-type="supplementary-material">
      <label>Appendix</label>
      <title>Supplementary material</title>
      <p>The following is the supplementary data to this article:<supplementary-material content-type="local-data" id="ec0010"><caption><title>AppendixâS1</title><p>Dystroplex, a targeted NGS gene panel in alpha-dystroglycanopathies.</p></caption><media xlink:href="mmc1.docx"/></supplementary-material></p>
    </sec>
    <ack id="ac0010">
      <title>Acknowledgements</title>
      <p>The authors thank EuroBioBank and Telethon Network of Genetic Biobanks (GTB12001H) for providing biological samples. We acknowledge the contribution of Dr Raffaello Canapicchi, who reviewed the MRI data, and Catherine J. Wrenn, who provided expert editorial assistance.</p>
      <p>This work was partially funded by <funding-source id="gsp0010">Telethon Foundation</funding-source> grants (GUP11001 to FMS; GUP13004 to AD, GA, and LP).</p>
    </ack>
    <fn-group>
      <fn id="s0025" fn-type="supplementary-material">
        <label>Appendix</label>
        <p>Supplementary data to this article can be found online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.nmd.2016.05.003" id="iw0010">doi:10.1016/j.nmd.2016.05.003</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="f0010">
      <label>Fig.â1</label>
      <caption>
        <p>Brain MRI in a patient with CMD carrying a mutation in <italic>TMEM5</italic>. (AâC) Coronal, axial and sagittal FSE T<sub>2</sub>-weighted images showing bilateral frontotemporal polymicrogyria (white arrow). (D, E) Axial FLAIR and (F) coronal FSE T2-weighted images revealing patchy, confluent frontoparietal white matter hyperintensities, bilaterally distributed (white arrow). In F as well as in G (axial T2-weighted image) cerebellar anomalies are evident. The latter include abnormal orientation of the cerebellar folia, an irregular gray matter-white matter junction (black arrows) and multiple small subcortical cysts in both cerebellar hemispheres (white arrow heads). In G the cleft in the ventral pons (note the black arrow head) and an enlarged and dysmorphic fourth ventricle (star) are also evident. (H) Sagittal T1-weighted image demonstrating hypoplasia of the pons (white arrow) and a mildly enlarged tectum (white arrow head). (I) Reconstruction of MIP 3D FIESTA image showing bilateral cochlear dysplasia, with fusion of the middle and apical cochlear turns, suggestive of Mondini-type deformity (white arrow). R, right; L, left.</p>
      </caption>
      <graphic xlink:href="nmd3182-fig-0001"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>